Definitive Contract HHSD200201793273C

Award Date 4/1/17
Potential Completion Date 3/31/18
Potential Value $2.3B
Federal Agency
CDC Pittsburgh
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Whitehouse Station, Readington Township, NJ, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
7
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $29,475,985.60 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, for the provision of various adult vaccines. The contract has a period of performance from July 1, 2015, to June 30, 2016, and is a firm fixed-price contract. Merck is a large pharmaceutical manufacturer that has been a critical partner in supplying essential vaccines and pharmaceutical products to support federal healthcare...
This is a $68,321,497.07 definitive contract awarded to Merck Sharp & Dohme LLC, doing business as Merck, by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. The contract is for the provision of various vaccines, including MMR, varicella, hepatitis, pneumococcal, tetanus, diphtheria, human papillomavirus, and meningococcal vaccines. This contract is not set aside and is part of Merck's larger portfolio of federal contracts, including indefinite delivery vehicles...
This contract award is for Merck Sharp & Dohme LLC, doing business as Merck, to provide vaccines to the U.S. Department of Health and Human Services. The $112,703.00 firm fixed-price delivery order falls under Merck's General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. The contract has no set-aside designation. Merck, a for-profit manufacturer, is the prime contractor. The contract supports the Centers for Disease Control and...
Merck Sharp & Dohme LLC was awarded a firm fixed price, definite contract valued at $75,294,061.41 by the Department of Health and Human Services Centers for Disease Control and Prevention to provide adult vaccines with performance through June 30, 2018. As the prime contractor, Merck will deliver a range of pharmaceutical products and vaccines from its Whitehouse Station, New Jersey place of performance to support the CDC's immunization programs. No set-aside designation was applied to this...
This is a delivery order contract awarded to Merck Sharp & Dohme LLC, doing business as Merck, by the Department of Health and Human Services Office of the Assistant Secretary for Administration. The contract is for the provision of vaccines, with a potential value of $124,256.21. The contract is not set-aside and falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). As a leading manufacturer of pharmaceuticals and vaccines, Merck has received numerous federal...
This is a delivery order awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The $95,935.20 firm fixed-price award is for the supply of vaccines to be delivered by October 28, 2017. It was placed under Merck's Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract does not have a set-aside designation. Merck holds several...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Merck Sharp & Dohme Corp. for the "MERCK PEDIATRIC VACCINE CONTRACT". The contract has a firm fixed price pricing type and a ceiling value of $39,055,333,994.98. The period of performance is from April 1, 2010 to March 31, 2011, and the place of performance is West Point, Pennsylvania. This contract was not set aside for any specific business category. The...
This is a Firm Fixed Price delivery order awarded by the Department of Health and Human Services (HHS) to Merck Sharp & Dohme LLC, doing business as Merck, a for-profit manufacturer of pharmaceuticals and vaccines. The $119,849.96 contract is for the delivery of Merck vaccines and is not associated with any set-aside program. Merck holds multiple federal contracts with agencies such as the Department of Veterans Affairs, Department of Defense, and Centers for Disease Control and Prevention...
Merck Sharp & Dohme LLC, doing business as Merck, was awarded a $119,128.44 firm fixed price delivery order contract by the Department of Health and Human Services Office of the Assistant Secretary for Administration for the supply of vaccines. The contract is not set aside. Merck is a for-profit manufacturer of pharmaceuticals and vaccines that holds multiple federal contracts and blanket purchase agreements with agencies such as the Centers for Disease Control and Prevention, Department of...
This federal contract award MERCK VACCINES FOR STOCK was issued by the Office of the Assistant Secretary for Administration, a civilian agency, to Merck Sharp & Dohme LLC (doing business as Merck), a major pharmaceutical manufacturer and supplier. The $88,659.80 firm fixed-price delivery order was placed against Merck's Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract does not have a set-aside designation. Merck is a subsidiary of Schering Plough...

This is a federal contract award to Merck Sharp & Dohme LLC, doing business as Merck, by the Department of Health and Human Services Centers for Disease Control and Prevention. The contract is valued at $2,296,282,738.69 and is for the delivery of vaccines under the Vaccines for Children program. The contract is a definitive contract with a firm fixed price and has a completion date of March 31, 2018. Merck, a for-profit manufacturer of goods, is the prime contractor for this award, which does not have a set-aside designation. The contract provides pediatric and adult vaccines for diseases such as measles, mumps, rubella, hepatitis, meningitis, tetanus, influenza, and COVID-19. Merck has received previous awards from the CDC, Department of Veterans Affairs, and other federal agencies for vaccine and pharmaceutical products and services.

Generated 3/23/24, 6:58 PM